| Viral Therapy in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Did Not Respond to Platinum Chemotherapy (NCT00602277) | National Cancer Institute (NCI) | 2008-04-01 |
| Aflibercept in Treating Young Patients With Relapsed or Refractory Solid Tumors (NCT00622414) | National Cancer Institute (NCI) | 2008-04-01 |
| Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia (NCT00666588) | National Cancer Institute (NCI) | 2008-04-01 |
| Viral Therapy in Treating Patients With Metastatic Melanoma (NCT00651157) | National Cancer Institute (NCI) | 2008-04-01 |
| Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma (NCT00662506) | National Cancer Institute (NCI) | 2008-04-01 |
| Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma (NCT00665470) | National Cancer Institute (NCI) | 2008-04-01 |
| Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor (NCT00324987) | National Cancer Institute (NCI) | 2008-04-01 |
| Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery (NCT00576654) | National Cancer Institute (NCI) | 2008-03-18 |
| SNX-5422 to Treat Solid Tumor Cancers and Lymphomas (NCT00644072) | National Cancer Institute (NCI) | 2008-03-07 |
| Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer (NCT00577889) | National Cancer Institute (NCI) | 2008-03-01 |
| IMC-A12 in Treating Patients With Advanced Liver Cancer (NCT00639509) | National Cancer Institute (NCI) | 2008-03-01 |
| Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia (NCT00571558) | National Cancer Institute (NCI) | 2008-03-01 |
| Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer (NCT00923845) | National Cancer Institute (NCI) | 2008-03-01 |
| S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery (NCT00617708) | National Cancer Institute (NCI) | 2008-03-01 |
| A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer (NCT00637481) | National Cancer Institute (NCI) | 2008-03-01 |
| Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma (NCT00602641) | National Cancer Institute (NCI) | 2008-02-29 |
| Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer (NCT00923273) | National Cancer Institute (NCI) | 2008-02-29 |
| Natural History Study of Patients With Neurofibromatosis Type I (NCT00924196) | National Cancer Institute (NCI) | 2008-02-25 |
| Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood (NCT00923910) | National Cancer Institute (NCI) | 2008-02-22 |
| Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer (NCT00625846) | National Cancer Institute (NCI) | 2008-02-22 |
| Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS) (NCT01131312) | National Cancer Institute (NCI) | 2008-02-20 |
| Satraplatin and Prednisone to Treat Prostate Cancer (NCT00634647) | National Cancer Institute (NCI) | 2008-02-19 |
| Phase II Study of Vandetanib in Individuals With Kidney Cancer (NCT00566995) | National Cancer Institute (NCI) | 2008-02-07 |
| Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer (NCT01445405) | National Cancer Institute (NCI) | 2008-02-05 |
| Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders (NCT00588991) | National Cancer Institute (NCI) | 2008-02-04 |
| AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma (NCT00659360) | National Cancer Institute (NCI) | 2008-02-01 |
| Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma (NCT00516295) | National Cancer Institute (NCI) | 2008-02-01 |
| AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination Chemotherapy (NCT00638937) | National Cancer Institute (NCI) | 2008-02-01 |
| Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer (NCT00450749) | National Cancer Institute (NCI) | 2008-02-01 |
| Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia (NCT00602459) | National Cancer Institute (NCI) | 2008-01-15 |
| Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme (NCT00540722) | National Cancer Institute (NCI) | 2008-01-01 |
| Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma (NCT00610311) | National Cancer Institute (NCI) | 2008-01-01 |
| Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer (NCT00607594) | National Cancer Institute (NCI) | 2008-01-01 |
| Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma (NCT00612222) | National Cancer Institute (NCI) | 2008-01-01 |
| Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia (NCT00602771) | National Cancer Institute (NCI) | 2008-01-01 |
| Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia (NCT00612612) | National Cancer Institute (NCI) | 2008-01-01 |
| Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma (NCT00397982) | National Cancer Institute (NCI) | 2008-01-01 |
| IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor (NCT00609141) | National Cancer Institute (NCI) | 2008-01-01 |
| Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer (NCT00551070) | National Cancer Institute (NCI) | 2007-12-17 |
| Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer (NCT00565851) | National Cancer Institute (NCI) | 2007-12-06 |
| Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia (NCT00588809) | National Cancer Institute (NCI) | 2007-12-01 |
| Vandetanib to Treat Advanced Kidney Cancer (NCT01372813) | National Cancer Institute (NCI) | 2007-12-01 |
| Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer (NCT00357760) | National Cancer Institute (NCI) | 2007-12-01 |
| Obatoclax and Bortezomib in Treating Patients With Aggressive Relapsed or Recurrent Non-Hodgkin Lymphoma (NCT00538187) | National Cancer Institute (NCI) | 2007-12-01 |
| Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors (NCT00972205) | National Cancer Institute (NCI) | 2007-12-01 |
| Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine (NCT00559949) | National Cancer Institute (NCI) | 2007-12-01 |
| Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage (NCT00589290) | National Cancer Institute (NCI) | 2007-12-01 |
| Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor (NCT00569127) | National Cancer Institute (NCI) | 2007-12-01 |
| Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma (NCT00553644) | National Cancer Institute (NCI) | 2007-11-15 |
| SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma (NCT01445392) | National Cancer Institute (NCI) | 2007-11-14 |
| Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer (NCT00433511) | National Cancer Institute (NCI) | 2007-11-02 |
| Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer (NCT00604721) | National Cancer Institute (NCI) | 2007-11-01 |
| FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer (NCT00559377) | National Cancer Institute (NCI) | 2007-11-01 |
| VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer (NCT00462826) | National Cancer Institute (NCI) | 2007-11-01 |
| Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU (NCT00520975) | National Cancer Institute (NCI) | 2007-11-01 |
| AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer (NCT00528645) | National Cancer Institute (NCI) | 2007-11-01 |
| Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer (NCT00589472) | National Cancer Institute (NCI) | 2007-11-01 |
| Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery (NCT00553332) | National Cancer Institute (NCI) | 2007-11-01 |
| Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia (NCT00563290) | National Cancer Institute (NCI) | 2007-11-01 |
| Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy (NCT00527124) | National Cancer Institute (NCI) | 2007-11-01 |
| Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System (NCT00520130) | National Cancer Institute (NCI) | 2007-10-30 |
| Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer (NCT00551421) | National Cancer Institute (NCI) | 2007-10-01 |
| Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer (NCT01445379) | National Cancer Institute (NCI) | 2007-10-01 |
| Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer (NCT00093496) | National Cancer Institute (NCI) | 2007-10-01 |
| Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery (NCT00559507) | National Cancer Institute (NCI) | 2007-10-01 |
| 1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery (NCT00567931) | National Cancer Institute (NCI) | 2007-10-01 |
| Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer (NCT00629226) | National Cancer Institute (NCI) | 2007-10-01 |
| Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer (NCT00378703) | National Cancer Institute (NCI) | 2007-09-14 |
| Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer (NCT00512668) | National Cancer Institute (NCI) | 2007-09-01 |
| R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer (NCT00544596) | National Cancer Institute (NCI) | 2007-09-01 |
| Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer (NCT00535119) | National Cancer Institute (NCI) | 2007-09-01 |
| Sunitinib in Treating Patients With Relapsed Multiple Myeloma (NCT00514137) | National Cancer Institute (NCI) | 2007-09-01 |
| Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy (NCT00486642) | National Cancer Institute (NCI) | 2007-09-01 |
| Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone (NCT00522392) | National Cancer Institute (NCI) | 2007-09-01 |
| Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer (NCT00416455) | National Cancer Institute (NCI) | 2007-09-01 |
| Aflibercept in Treating Patients With Myelodysplastic Syndromes (NCT00509249) | National Cancer Institute (NCI) | 2007-09-01 |
| Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas (NCT00553189) | National Cancer Institute (NCI) | 2007-08-09 |
| Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery (NCT00281957) | National Cancer Institute (NCI) | 2007-08-01 |
| AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy (NCT00513071) | National Cancer Institute (NCI) | 2007-08-01 |
| Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer (NCT00454142) | National Cancer Institute (NCI) | 2007-08-01 |
| Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma (NCT00924001) | National Cancer Institute (NCI) | 2007-08-01 |
| Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00398112) | National Cancer Institute (NCI) | 2007-08-01 |
| Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors (NCT00521144) | National Cancer Institute (NCI) | 2007-08-01 |
| Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer (NCT00514046) | National Cancer Institute (NCI) | 2007-07-20 |
| Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery (NCT00324805) | National Cancer Institute (NCI) | 2007-07-19 |
| Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer (NCT00516243) | National Cancer Institute (NCI) | 2007-07-01 |
| Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer (NCT00504153) | National Cancer Institute (NCI) | 2007-07-01 |
| Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery (NCT00513292) | National Cancer Institute (NCI) | 2007-07-01 |
| Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients (NCT00489372) | National Cancer Institute (NCI) | 2007-07-01 |
| Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00513435) | National Cancer Institute (NCI) | 2007-07-01 |
| Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00507767) | National Cancer Institute (NCI) | 2007-07-01 |
| HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers (NCT00491335) | National Cancer Institute (NCI) | 2007-06-18 |
| Pilot Study of Educational Interventions in Pediatric Hematopoietic Stem Cell Donors to Increase Knowledge of Donation and Transplantation Procedures (NCT01445158) | National Cancer Institute (NCI) | 2007-06-18 |
| Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma (NCT00923351) | National Cancer Institute (NCI) | 2007-06-02 |
| Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer (NCT00492089) | National Cancer Institute (NCI) | 2007-06-01 |
| Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction (NCT00499811) | National Cancer Institute (NCI) | 2007-06-01 |
| Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy (NCT00499369) | National Cancer Institute (NCI) | 2007-06-01 |
| Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered Lymphocytes (NCT00509288) | National Cancer Institute (NCI) | 2007-06-01 |
| Sunitinib in Treating Patients With Recurrent Malignant Gliomas (NCT00499473) | National Cancer Institute (NCI) | 2007-06-01 |
| Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With Pontine Glioma (NCT00387790) | National Cancer Institute (NCI) | 2007-06-01 |